Is a complete NSE/WOCKPHARMA research report available?

No complete published report is available for nse/WOCKPHARMA (NSE/WOCKPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/WOCKPHARMA stock profile: metrics, valuation and analysis

Market cap	354.1B
Revenue (ttm)	36.5B
Net income (ttm)	4.1B
EPS (ttm)	₹25.2
Shares out	162.5M
P/E (trailing)	86.5x
Volume	1,109,915
Beta	0.97

All NSE/WOCKPHARMA indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

INR

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2,564
Employees Change	268%
Employees Change Percent	11.67
Enterprise value	INR 373.7B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.51
Industry PE Fwd	33.85
Isin	INE049B01025
Last refreshed	2026-09-12
Market cap	INR 354.1B
Price	INR 2,179
Price currency	INR
Rev Per Employee	14,247,269.89x
Sector	Healthcare
Sector PE	48.04
Sector PE Fwd	38.4
Sic	2834
Symbol	nse/WOCKPHARMA
Website	https://www.wockhardt.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.15%
EV Earnings	91.38x
EV/EBIT	64.44x
EV/EBITDA	46.35x
EV/FCF	147.14x
EV/Sales	10.23x
FCF yield	0.72%
P/B ratio	6.71x
P/E ratio	86.53x
P/S ratio	9.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.88%
EBITDA Margin	20.48%
FCF margin	7.34%
Gross margin	65.15%
Gross Profit	INR 23.8B
Gross Profit Growth	27%
Gross Profit Growth Q	28.48%
Gross Profit Growth3 Y	17.34%
Gross Profit Growth5 Y	7.55%
Net Income	INR 4.1B
Net Income Growth Qo Q	-36.14%
Net Income Growth Quarters	4%
Net Income Growth Years	3%
Pretax Margin	12.67%
Profit Margin	11.2%
Profit Per Employee	INR 1.6M
Profitable Quarters	INR 4
Profitable Years	1
Roa5y	0.89
Roe5y	-6.61
ROIC	7.59
Roic5y	1.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.84%
Cagr15y	13.25%
Cagr1y	39.73%
Cagr20y	9.82%
Cagr3y	103.06%
Cagr5y	41.59%
Div CAGR10	0%
Div CAGR3	0%
Div CAGR5	14.87%
EPS Growth Qo Q	-35.94
EPS Growth Quarters	4
EPS Growth Years	3
FCF Growth3 Y	31.78%
OCF Growth10 Y	18.47%
OCF Growth3 Y	36.6%
Revenue Growth	20.4x
Revenue Growth Q	25.88x
Revenue Growth Qo Q	-11.86x
Revenue Growth Quarters	3x
Revenue Growth Years	3x
Revenue Growth3 Y	10.6x
Revenue Growth5 Y	4.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 6.8B
Debt	INR 22.3B
Debt EBITDA	INR 2.77
Debt Equity	INR 0.42
Debt FCF	INR 8.79
Equity	INR 52.8B
Interest Coverage	2.74
Net Cash	INR -15.5B
Net Cash By Market Cap	INR -4.39
Net Debt EBITDA	INR 2.08
Net Debt Equity	INR 0.29
Net Debt FCF	INR 6.11
Tangible Book Value	INR 19.9B
Tangible Book Value Per Share	INR 123
WACC	9.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.03%
Dividend per share	INR 0
Last Dividend	INR 10

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	179.86%
1Y total return	39.7%
200-day SMA	1,598.6
3Y total return	737.67%
50-day SMA	1,935.9
50-day SMA vs 200-day SMA	50over200
5Y total return	469.01%
All Time High	2,422.3
All Time High Change	-10.04%
All Time High Date	2026-06-01
All Time Low	66.5
All Time Low Change	3,176.99%
All Time Low Date	2009-04-01
ATR	80.38
Beta	0.97
Beta1y	1.05
Beta2y	0.77
Ch YTD	50.69
High	2,237
High52	2,422.3
High52 Date	2026-06-01
High52ch	-10.04%
Low	2,167.3
Low52	1,086.7
Low52 Date	2026-03-23
Low52ch	100.53%
Ma50ch	12.57%
Price vs 200-day SMA	36.32%
RSI	64.36
RSI Monthly	68.66
RSI Weekly	67.95
Sharpe ratio	0.92x
Sharpe Ratio3y	1.59x
Sharpe Ratio5y	0.78x
Sortino ratio	1.84
Sortino Ratio3y	3.04
Sortino Ratio5y	1.48
Total Return	-1.03%
Tr YTD	50.69
Tr15y	546.2%
Tr1m	12.84%
Tr1w	4.33%
Tr3m	18.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	76,589,567%
Net Borrowing	1,530,000,000
Shares Insiders	2.47%
Shares Institutions	13.91%
Shares Out	162,492,169
Shares Qo Q	-0.37%
Shares Yo Y	1.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 2.5B
Adjusted OCF	3,860,000,000
Average Volume	1,065,531.45x
Bv Per Share	300
CAPEX	INR -1.4B
Ch10y	154.4
Ch15y	453.2
Ch1m	12.84
Ch1w	4.33
Ch1y	39.7
Ch20y	433.7
Ch3m	18.89
Ch3y	737.7
Ch5y	424.4
Ch6m	64.17
Change	-1.86%
Change From Open	-0.95
Close	2,220.6
Days Gap	-0.93
Depreciation Amortization	1,682,500,000
Dollar Volume	2,418,726,768
Earnings Date	2026-11-14
EBIT	INR 5.8B
EBITDA	INR 7.5B
EPS	INR 25.19
F Score	3
FCF	INR 2.5B
FCF EV Yield	0.68x
FCF Per Share	INR 15.63
Financing CF	-540,000,000
Fiscal Year End	March
Founded	1,967
Graham Number	428.98164
Graham Upside	-80.31
Income Tax	INR 490M
Investing CF	-2,410,000,000
Is Primary Listing	1
Last Earnings Date	2026-08-10
Last Report Date	2026-06-30
Last Split Date	2004-04-28
Last Split Type	Forward
Ma150	1,671.5
Ma150ch	30.37%
Ma20	1,984.1
Ma20ch	9.83%
Net CF	1,050,000,000
Next Earnings Date	2026-11-14
Open	2,200
P FCF Ratio	139.4
P FCF Ratio SBC	141.7
P OCF Ratio	90.8
P OCF Ratio SBC	91.74
Position In Range	17.07
Price Date	2026-09-11
Price EBITDA	INR 47.33
Ptbv Ratio	17.77
Relative Volume	1.07x
Revenue	36,530,000,000x
SBC By Revenue	0.12x
Share Based Comp	40,000,000
Tax By Revenue	1.34x
Tax Rate	10.58%
Tr20y	550.65%
Tr6m	64.17%
Volume	1,109,915

NSE/WOCKPHARMA (NSE/WOCKPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/WOCKPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/WOCKPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/WOCKPHARMA

Frequently asked questions